Quick ReadPlain-language overview · read this first
Air Liquide is one of the global leaders in industrial and medical gases, selling products such as oxygen, nitrogen, and hydrogen that factories and hospitals cannot operate without. The report rates it as “Watch”: the company is strong, but buying it at the current price is not cheap.
How does it make money? In most cases, it first installs gas supply equipment and pipelines at the customer’s plant, then signs a long-term contract. Once the gas starts flowing, it cannot simply stop, and it is also hard for another supplier to replace it. That makes revenue recurring, stable, and predictable, which is the most valuable part of this business. In 2025, the company generated about 26.9 billion euros in sales and, after all costs and deductions, kept about 3.5 billion euros in profit. Margins have been improving in recent years, debt has also been declining year by year, and the foundation is very solid.
What about the current price? Based on its current earnings, buying the whole company would take roughly 30 years to pay back. The report estimates the current price at around 183 euros, which is already on the expensive side. The report sees a truly attractive buying range at 100 to 130 euros. Buying above that is no longer buying cheap; it means paying extra for “quality.”
There are two main things to watch. First, the company has invested a lot of money in new projects such as hydrogen energy and decarbonization, and whether those investments can earn an adequate return has not yet been proven. Second, the price is already set very high. If growth or profit falls short of expectations in any year, the share price could pull back meaningfully. The report’s conclusion is that this is a good company worth tracking for the long term, but it is better to wait until it falls to a cheaper level before considering it. There is no need to rush in now.
The above is only a plain-English explanation of this report and is not investment advice. Stock markets involve risk; invest with caution.
LeadAir Liquide is one of the global leaders in industrial and medical gases, serving 4.3 million customers and patients across 59 countries, with oxygen, nitrogen, hydrogen, electronics specialty gases, and medical gases deeply embedded in customer production processes. In 2025, revenue reached EUR 26.94 billion, operating cash flow was EUR 6.52 billion, recurring ROCE stayed solid at 11.2%, and net debt continued to fall over five years to EUR 8.42 billion. Rating Watch: a classic infrastructure, consumables, and long-term service contract compounder with strong contract stickiness and a deep moat, yet the current share price of about EUR 183 implies roughly 30x P/E and already reflects much of its quality, leaving insufficient margin of safety.
Conclusion First
Investment rating: Watch. If Air Liquide is viewed as a business one would want to acquire for the long term, my assessment of the business itself is high: it is one of the global leaders in industrial and medical gases, with diversified customers, strong contract stickiness, resilient cash flow, and an asset network that is hard to replicate. Over the past few years, despite a complex macro environment, it has continued to expand margins and reduce net leverage. In 2025, the company generated revenue of EUR 26.94 billion, recurring operating income of EUR 5.58 billion, net profit of EUR 3.52 billion, and cash flow from operating activities before changes in working capital of EUR 6.86 billion. Comparable growth continued in Q1 2026, while the investment backlog rose to EUR 5.5 billion.
Core judgment. First, this is an understandable business that resembles an “infrastructure + consumables + long-term service contracts” model: oxygen, nitrogen, hydrogen, electronics specialty gases, and medical oxygen are often part of the customer's production chain rather than discretionary spending. Second, it is also a good business: high entry barriers, scale, pipelines, on-site supply units, certification, and long-term contracts together form its moat. Third, the main issue is price rather than quality: based on share count in early June 2026 and Reuters market capitalization data, the share price was roughly around EUR 183, implying about 30x 2025 P/E, about 14x EV/EBITDA, and about 40x P/FCF on a strict basis. For a balanced but conservative long-term investor who requires a margin of safety, that is no longer cheap.
Is there a margin of safety at the current price: not obvious. My conclusion is that the company is good, while the current price has already pulled forward a meaningful portion of its excellent qualities. If you already own it, this looks more like a high-quality asset that can be held patiently, with strict control over position size and expected returns. If you do not own it yet, I would rather wait for the market to offer a thicker margin of safety.
Suitable investor type. It is more suitable for long-term value investors, quality-oriented investors, and conservative compounding investors who can accept the reality of “a good company at a price that is not cheap”. It is less suitable for growth investors chasing it as a high-beta, high-return opportunity. This company is closer to a high-quality industrial utility-like asset than a high-velocity, asset-light platform.
Largest uncertainty. The three most important uncertainties are: first, how much of recent high capital expenditure is truly high-return growth investment rather than asset-heavy expansion lifted by the energy transition narrative; second, whether the recovery in European large industrial demand can materialize, especially the commercialization pace of large industrial and hydrogen-related projects; third, the current valuation demands sustained high-quality execution, and if growth or margins fall short, valuation compression could significantly reduce returns over the next decade.
Business Understanding
Air Liquide's core business is providing “production, storage and transport, on-site supply units, pipelines, specialty gas formulations, equipment, and services” around irreplaceable small-molecule gases in industrial and healthcare settings. In 2025, Gas & Services accounted for about 97% of group revenue. Within Gas & Services, the business lines were roughly Large Industries 27%, Industrial Merchant 47%, Electronics 9%, and Healthcare 17%. This means the company's profit engine is not one-off engineering work, but recurring gas supply relationships deeply tied to customer production processes.
Who are its customers? Large industrial customers include refining, chemicals, steel, glass, energy, and large-scale manufacturing; Industrial Merchant customers are more fragmented; Electronics serves semiconductors and advanced manufacturing; Healthcare serves hospitals, home healthcare, and patients. The company discloses that it serves 4.3 million customers and patients across 59 countries. This is not a typical company dependent on one large customer. More precisely, it is diversified at the group level, while at the individual on-site supply project level it often forms long-term ties with specific customers. That is the normal business model of the industrial gas industry.
How does it charge? There are broadly three models. The first is on-site and pipeline supply, usually under long-term contracts. Customers cannot easily stop, and the supplier is also hard to replace. The second is Industrial Merchant, which sells through cylinders, liquid tankers, and distribution networks. Individual orders are small, but the customer base is large and price management matters. The third is Electronics and Healthcare, where unit prices are higher, certification and quality requirements are stricter, and customers switch more cautiously. The company has repeatedly emphasized that energy price changes in Large Industries contracts can often be passed through contractually to customers, while Industrial Merchant relies on price management capability to address inflation.
The repeatability and predictability of revenue are what long-term shareholders should value most in this company. In its 2021 earnings presentation, the company explicitly wrote that its business model allows energy volatility to be automatically passed through to Large Industries customers and enables rapid Industrial Merchant price adjustments. In 2023, 2024, 2025, and the Q1 2026 report, the company repeatedly used the language of resilience, efficiency gains, continued margin improvement, and Healthcare being independent of the industrial cycle. These claims are broadly supported by the financial results. In Q1 2026, Healthcare still grew 4.0%, Industrial Merchant grew 2.7%, and Electronics grew 2.9%, showing that even when Large Industries is weak, the portfolio mix can offset part of the volatility.
The cost structure is not light. At its core, the company is an asset-heavy network business, with costs including energy, raw materials, depreciation, logistics, labor, and maintenance. In 2025, the company spent about EUR 3.84 billion on purchases of property, plant, equipment, and intangible assets, while depreciation and amortization were EUR 2.56 billion. Capital intensity is not low. In other words, this is a good business with high cash flow quality, but not a light-capital business. The positive point is that it is not continuously burning cash to maintain superficial growth. In recent years, even with high capex, it has still covered dividends and reduced net debt.
Can I understand this business? I think yes. The difficulty level is roughly “medium-low.” There are many technical details, but the economic logic is clear: customers need gases, supply systems are embedded in customer plants and processes, contract periods are long, replacement costs are high, and regional networks have scale effects. As a result, high-quality players can earn cash steadily over long periods. If the stock market closed for five years, I would be willing to own this business, provided the purchase price is reasonable. Business understandability score: 4.5/5.
Industry, Competition, and Moat
The industrial gas industry as a whole is not a high-growth industry. It is a high-quality structure within a mature industry. It is mature because core demand for oxygen, nitrogen, argon, and other gases has existed for many years. It is not declining because electronics, healthcare, semiconductors, low-carbon hydrogen, carbon capture, and advanced materials are creating new growth curves. These are also the growth themes Air Liquide itself has emphasized most in recent years: Electronics, Healthcare, decarbonization, and hydrogen. The investment backlog reached EUR 4.9 billion at the end of 2025 and rose further to EUR 5.5 billion in Q1 2026, indicating that the new project pipeline remains strong.
In terms of competition, this is not a crowded, fragmented, undisciplined industry. It is a classic global oligopoly + local network competition industry. The most important comparables are Linde, Air Products, and Nippon Sanso. The market generally assigns high valuations to these leaders, reflecting industry stability, long-term contract visibility, network effects, and strong cash flow resilience. Air Liquide's credit rating page even directly attributes its credit strengths to its leading position in the industrial gas market, highly visible revenue, and high network density. Scope also bases its rating on strong profitability, market position, expertise, diversification, and prudent financial policy.
My moat assessment is as follows. Brand advantage exists, but it is not a consumer brand in the usual sense. It is a brand of industrial reliability and certification. Cost advantage and scale advantage are clear: large separation units, pipelines, distribution networks, purchasing scale, and local density jointly reduce unit cost. The network effect is not an internet-style network effect, but in industrial platforms and regional pipeline systems it appears as “the denser the network, the more economical marginal projects become.” Switching costs are strong, especially in on-site supply, electronics specialty gases, and Healthcare. Licensing, regulation, and certification barriers are also important, especially in Healthcare and Electronics. Data advantage is not core. Corporate culture and operating capability are part of the key moat. The company has lifted margins through efficiency gains and price management for several consecutive years, which shows that execution quality is real.
Is this moat widening, stable, or narrowing? My judgment is that it is overall stable and slightly widening. The widening comes from Electronics and decarbonization projects, regional density, and the stronger position in Korea after the DIG Airgas acquisition. The uncertain part comes from hydrogen project returns that have not yet been fully proven, and from still-weak demand in some European large industrial segments. In Q1 2026, the company said that after completing the DIG Airgas acquisition, revenue scale in Korea would reach about EUR 900 million. It also has 78 dedicated units for Electronics customers in Japan and 54 related units in Taiwan. These cannot be replicated quickly or with low capital.
Does the company have pricing power? The answer is yes, but it varies by business line. Large Industries relies more on energy pass-through under contract terms; Industrial Merchant shows continuous price adjustment capability; Healthcare and Electronics reflect high added value and high reliability. In both 2023 and Q1 2026, the company explicitly mentioned that the Industrial Merchant price effect remained strong, with Industrial Merchant prices rising 3.4% in Q1 2026. This shows that in an inflationary environment, the company is not a passive victim of cost pressure.
Can it remain profitable in an economic downturn? Historically, yes. From 2021 to 2025, whether facing post-pandemic recovery, Europe's energy shock, currency disturbance, or geopolitical uncertainty, the company maintained profitability, dividends, and margin improvement. It should be noted that Large Industries is not completely immune to the cycle, but the group structure is diversified enough, and Healthcare has defensive characteristics. Industry attractiveness score: 4/5. Moat strength score: 4/5.
Management and Capital Allocation
From a governance framework perspective, Air Liquide's board quality is a positive. After the 2025 shareholder meeting, the company maintained a board of 14 members, including 12 elected by shareholders and 2 employee directors. Independent directors accounted for 83%, and women accounted for 42%. The board system also requires each director, except employee directors, to hold at least 500 registered shares. For a large French listed company, this governance structure is sound and relatively mature.
On honesty and long-term orientation, management leaves an overall positive impression. The company does not center its story on the short-term share price. It continues to focus on margins, ROCE, cash flow, the investment backlog, and decarbonization opportunities. More importantly, the operating targets management has communicated in recent years, such as continuing to improve margins under the ADVANCE plan, keeping recurring ROCE above 10%, and driving a high level of investment decisions, have broadly been delivered in financial results. In 2023, the company doubled its original margin improvement target. In 2024, it raised and extended the target to 2026. In Q1 2026, it further lifted the cumulative 2022-2027 margin improvement target to 560 basis points. Frequent target increases are not inherently a strength. Raising targets while also delivering them is the real strength.
On capital allocation, the company has mainly done five things over the past few years: continuous reinvestment, annual dividend increases, very limited large-scale buybacks, moderate portfolio management, and strategic M&A. The dividend increased from EUR 2.90 per share for 2021 to a proposed EUR 3.70 per share for 2025, with a smooth growth path. Buybacks are very limited. In 2025, treasury share purchases were only about EUR 4 million, far from using buybacks to beautify EPS. For long-term shareholders, this style is closer to “steady capital allocation” than an aggressive shareholder return machine.
A specific point on share count needs explanation: Air Liquide has a long tradition of free share allocations / bonus shares. On June 10, 2026, it will conduct its 33rd free share allocation, at a ratio of 1 new share for every 10 shares held. This mechanism periodically increases the number of outstanding shares, but it is closer to a capitalization of reserves for all shareholders than selective dilution for management. Therefore, when analyzing EPS and dividends per share, one must note that the company's figures usually adjust historical per-share data accordingly.
On M&A, I think the assessment should be layered. Small or medium-sized disposals and bolt-on acquisitions generally look rational. DIG Airgas is a more significant strategic bet, with transaction consideration of about EUR 2.85 billion. Once completed, it will significantly strengthen the company's Korean footprint and help it capture semiconductor and battery-chain opportunities. The strategic logic is valid, and financially it remains within leverage ranges acceptable to management and rating agencies. But I must state clearly that whether this acquisition truly creates long-term value cannot yet be concluded today. For value investors, the right attitude is to track capital returns rather than praise a transformation story.
Compensation design also has some alignment. The company discloses that key indicators for executive long-term incentives include ROCE, total shareholder return, and changes in CO2 emissions. The CEO's fixed annual salary remained EUR 1.21 million in 2025, with no extra compensation for board membership. My view on this compensation design is that it is better than a pure EPS focus and more reasonable than simply chasing scale. However, because I could not verify the CEO's exact shareholding size from accessible materials, I cannot use “heavy executive ownership” as a strong bullish argument. Restraint is appropriate here. Management and capital allocation score: 4/5.
Financial Quality and Owner Earnings
Start with the five-year financial profile. On the surface, revenue rose sharply in 2022 and then declined slightly from 2023 to 2025, but this was mainly affected by energy pass-through and exchange rates. Looking at the company's comparable growth figures, 2021 to 2025 were approximately +8.2%, +7.0%, +3.7%, +2.6%, and +2.0%, still showing steady low-single-digit to mid-single-digit growth. More importantly, the recurring operating margin rose from 17.8% in 2021 to 20.7% in 2025, while recurring ROCE rose from 9.3% to 11.2%. For an asset-heavy industrial gas company, this is a very attractive quality improvement trajectory.
Key Financial Metrics
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (EUR 100mn) | 233.35 | 299.34 | 276.08 | 270.58 | 269.40 |
| Official comparable growth | 8.2% | 7.0% | 3.7% | 2.6% | 2.0% |
| Recurring operating margin | 17.8% | 16.2% | 18.4% | 19.9% | 20.7% |
| Net profit attributable to shareholders (EUR 100mn) | 25.72 | 27.59 | 30.78 | 33.06 | 35.18 |
| EPS (EUR) | 5.45 | 5.28 | 5.35 | 5.74 | 6.10 |
| Cash flow from operating activities before changes in working capital (EUR 100mn) | 52.92 | 62.55 | 63.57 | 65.39 | 68.55 |
| Net operating cash flow (EUR 100mn) | 55.71 | 58.10 | 62.63 | 63.22 | 65.18 |
| Purchases of property, plant, equipment, and intangible assets (EUR 100mn) | 29.17 | 32.73 | 33.93 | 35.25 | 38.43 |
| Strict free cash flow (EUR 100mn) | 26.54 | 25.37 | 28.70 | 27.97 | 26.75 |
| Net debt (EUR 100mn) | 104.48 | 102.61 | 92.21 | 91.59 | 84.16 |
| Deferred / recurring ROCE | 9.3% | 10.3% | 10.6% | 10.7% | 11.2% |
| Dividend / share | 2.90 | 2.95 | 3.20 | 3.30 | 3.70 |
Note: Revenue, margins, net profit, EPS, dividends, operating cash flow, capital expenditure, net debt, and ROCE for 2021-2025 are taken from Air Liquide's annual results activity reports and appendix cash flow statements. Reported growth in 2022 was materially affected by energy pass-through, so the table also emphasizes the company's official “comparable growth” metric.
This table reflects several crucial facts. First, margin improvement has been continuous, not a one-year accident in 2025. Second, net profit and cash flow match: in 2025, net profit attributable to shareholders was EUR 3.52 billion, net operating cash flow was EUR 6.52 billion, and depreciation and amortization were EUR 2.56 billion, indicating substantial verifiable cash flow behind accounting profit. Third, capital expenditure is indeed high, but the company has not fallen into the trap of needing ever more money as it grows. On the contrary, in recent years, despite high capital expenditure and continued dividends, net debt fell from EUR 10.45 billion in 2021 to EUR 8.42 billion in 2025.
Now consider balance sheet quality. Net debt was EUR 8.42 billion at the end of 2025, continuing to decline from 2024. Based on an estimate using recurring operating income before depreciation and amortization, net debt/EBITDA has fallen to about 1.0x, a clear improvement from about 1.65x in 2021. On credit ratings, S&P rates it A/A-1, Moody's rates it A2/P-1, and Scope rates it A/S-1. Rating agencies emphasize revenue visibility, network density, stable cash flow, and prudent financial policy. For an asset-heavy business, this represents very strong survivability.
On working capital, I do not see obvious red flags. In 2022, the company clearly explained that the increase in working capital mainly came from higher inventories and supply security under inflation. By 2023-2025, working capital changes in operating cash flow were EUR -154 million, EUR -155 million, and EUR -226 million, respectively, which is controllable. On the balance sheet, inventories rose from EUR 2.03 billion in 2023 to EUR 2.19 billion and then fell back to EUR 2.13 billion in 2025. Trade receivables were broadly stable from EUR 2.99 billion and then fell to EUR 2.87 billion. Trade payables declined to EUR 3.00 billion in 2025. Overall, this does not look like growth cosmetically supported by aggressive credit terms or inventory build-up.
My conclusion on financial quality is: profits are largely real cash profits rather than accounting profits that exist only on the income statement; growth does require high capital investment, but the company has not sacrificed the balance sheet for expansion; I found no obvious signs of financial fraud, aggressive accounting, or earnings manipulation. Of course, this is not an audit conclusion. It is an investment judgment based on consistency between public financial statements and cash flow.
Owner Earnings Analysis
Buffett-style owner earnings are not centered on “reported net profit.” The key is the cash a business can truly distribute to owners without damaging its competitive position. Using 2025 as an example, Air Liquide starts with net profit attributable to shareholders of EUR 3.518 billion, adds back depreciation and amortization of EUR 2.564 billion, and deducts additional working capital consumption of EUR 226 million. The debate is how much “maintenance capital expenditure” should be deducted. The company does not disclose maintenance capex in a strict sense, so this must be stated candidly: this part can only be estimated and should not be presented as a certain fact.
My conservative estimation method is as follows: in 2025, the company spent EUR 3.843 billion on purchases of property, plant, equipment, and intangible assets. During the same period, the investment backlog reached EUR 4.9 billion and then rose to EUR 5.5 billion in Q1 2026, while the company was also clearly accelerating in Electronics, steel decarbonization, and integration of the Korean acquisition. This suggests that total capex in recent years included a considerable share of growth investment rather than only “maintaining today's capacity.” Therefore, I conservatively estimate 2025 maintenance capex at around EUR 2.9 billion, slightly above that year's depreciation and amortization but significantly below total capex. This assumption is more conservative than “maintenance capex = depreciation” and closer to economic reality than “maintenance capex = all capex.”
Under this assumption, 2025 owner earnings are approximately: 3.518 + 2.564 - 2.900 - 0.226 = around EUR 2.96 billion. With a further safety buffer, I would place conservative owner earnings distributable to shareholders in the EUR 2.9 billion to EUR 3.1 billion range. Against a current market capitalization of about EUR 106.1 billion, the market is valuing Air Liquide at roughly 34-37x owner earnings. This does not fit the “cheap” category in a deep value sense. It is closer to being willing to pay a high price for high quality.
A useful cross-sectional observation is that from 2021 to 2025, strict free cash flow calculated as net operating cash flow minus capex was broadly between EUR 2.5 billion and EUR 2.9 billion, and over the long term it has not been much higher than net profit. This shows that the company's cash generation is good, but high capital intensity reinvests a large portion of operating cash back into the business. It is a high-quality cash flow machine, while it is not an asset-light platform where cash naturally pours heavily to shareholders. This distinction means valuation cannot receive an unlimited premium simply because the business is stable.
Valuation and Margin of Safety
I use three valuation methods and intentionally set assumptions conservatively, because the investment style here is “balanced and conservative.”
Owner Earnings Discount Method
I use the conservative owner earnings range above as the starting point and build three scenarios. To be clear: the following growth rates, discount rates, and terminal growth rates are my valuation assumptions, not company guidance. They are mainly based on the company's comparable growth over the past five years, margin improvement, ROCE level, investment backlog, and industry stability.
| Scenario | Starting owner earnings | First 10-year growth | Discount rate | Terminal growth | Implied intrinsic value per share |
|---|---|---|---|---|---|
| Conservative | EUR 2.9 billion | 4% | 9% | 2% | About EUR 85 |
| Base | EUR 3.05 billion | 6% | 8% | 2.5% | About EUR 129 |
| Bull | EUR 3.2 billion | 8% | 7.5% | 3% | About EUR 189 |
What this table tells me is not “one uniquely correct price.” It says that the current price of about EUR 183 is already close to the bull scenario and far above the conservative and base scenarios. For long-term value investors, that usually means the return distribution is not asymmetric. Either you believe it can maintain high-quality execution almost continuously over the next decade and enjoy a high valuation for a long time, or you should acknowledge that there is not enough margin of safety today.
Relative Valuation Method
At the current estimate of about EUR 183, Air Liquide roughly trades at about 30x P/E, about 3.9x P/B, about 14x EV/EBITDA, and about 40x P/FCF on a strict basis. Compared with peers, it is less expensive than Linde, but it is certainly not cheap. Relative to Air Products, it does not have a significant valuation discount, while it has a steadier execution record and fewer governance controversies. Relative to Nippon Sanso, it is clearly more expensive.
| Company | Main market | P/E | EV/EBITDA | P/B | Comment |
|---|---|---|---|---|---|
| Air Liquide | Paris | About 30x | About 14-15x | About 4.0x | High quality, but free cash flow yield is low |
| Linde | Nasdaq | About 33x | About 19x | Needs additional data | Strongest global leader; market assigns a higher premium |
| Air Products | NYSE | About 29x | About 17.7x | Needs additional data | Valuation is not low, and recent project and governance controversies are higher |
| Nippon Sanso | Tokyo | About 21x | About 9.5x | About 2.0x | Much cheaper, but the market also assigns a lower quality premium |
Note: Air Liquide multiples in the table are mainly calculated using Reuters market capitalization and the company's 2025 financial statements, with reference to Yahoo Finance statistics. Linde multiples come from Google Finance and Yahoo Finance. Air Products multiples come from Google Finance, Yahoo Finance, and Reuters / Reuters news. Nippon Sanso multiples come from CompaniesMarketCap, Yahoo Finance, and the company's share price page. Some P/B, P/FCF, and ROIC data could not be fully verified from accessible primary materials in this research, so they are marked “needs additional data.”
My interpretation is that relative valuation can show Air Liquide is not the most expensive name in the industry, but it cannot prove that it is cheap. These are two very different conclusions. If peers are all expensive, that at most means the market favors the industry overall. It does not mean buying today offers a margin of safety.
Asset and Liquidation Value Method
From an asset-based perspective, Air Liquide is not cheap. At the end of 2025, total shareholders' equity was about EUR 26.95 billion, including goodwill of EUR 13.82 billion and other intangible assets of EUR 1.56 billion. A rough estimate gives tangible net assets of only about EUR 11.56 billion. Against the current market capitalization of about EUR 106.1 billion, P/B is about 3.9x and P/tangible book is about 9x. This clearly shows that the market is buying long-term contracts, networks, customer relationships, process capabilities, and future cash flow rather than liquidation assets. So if you are looking for asset-discount stocks, Air Liquide does not belong in that category.
Combining the three methods, I arrive at the following ranges: Conservative intrinsic value range: EUR 85-110 per share. Reasonable intrinsic value range: EUR 120-150 per share. Bull intrinsic value range: EUR 175-205 per share.
At the current price of roughly EUR 183, the market price is clearly above the conservative range and mostly above the reasonable range. It is close to fair only under the bull range. For conservative investors, I think a 20%-30% margin of safety is needed. Therefore: Ideal buy price range: EUR 100-130. Acceptable hold price range: EUR 130-165. Clearly overvalued price range: above EUR 175.
This does not mean the share price above EUR 175 will definitely fall. It means that at that price, you are more likely buying the certainty of an excellent company than buying something below intrinsic value. For value investing, these two things should not be confused.
Risks, Comparisons, and Investment Checklist
I see six main categories of risk. Competition and industry risk: although industrial gases are an oligopoly industry, Linde, Air Products, and Nippon Sanso are all investing in key regions and high-growth end markets. Korea, Electronics, and decarbonization projects will not be free of competition. Technology and project risk: hydrogen, CCS, and decarbonization projects have narrative potential, but commercialization pace, policy subsidies, and customer start-up schedules are uncertain. Cyclical risk: Large Industries is still affected by industrial activity in Europe and Asia. Weakness in Large Industries in Europe and Asia in Q1 2026 is a reminder. M&A integration risk: the strategic logic of DIG Airgas is reasonable, but actual synergies and returns still need to be verified. Financial and interest rate risk: current leverage is low, but under asset-heavy expansion and continued dividends, leverage would rise again if cash returns fall short. Valuation risk: this is the largest risk right now, because a high valuation amplifies the market consequences of any small operating misstep.
If I were to write the strongest short thesis, it would probably be this: Air Liquide is an excellent company, but the market already knows it. Investors today are paying around 30x earnings for an industrial company that is cyclical, asset-heavy, requires sustained large investment, and still needs to prove returns on its new growth curves. That looks less like value investing and more like chasing a high-quality asset at a rich price. This bearish argument is not absurd. In my view, it is quite powerful. Especially when the U.S. 10-year Treasury yield is about 4.55% and the French 10-year government bond yield is about 3.72%, the free cash flow yield implied by Air Liquide's current share price does not offer especially generous risk compensation.
What facts would overturn the investment judgment? First, if margin improvement stops or reverses while management continues high-intensity capital expenditure, that would mean the capital allocation logic has gone wrong. Second, if recurring ROCE stays below 10% and new project returns do not rise, the investment story would weaken. Third, if leverage rises materially after DIG Airgas integration without cash flow improvement, the acquisition may not have created value. Fourth, if high-quality businesses such as Electronics, Healthcare, and Industrial Merchant also keep growing below the industry, the moat would need to be reassessed.
Compared with other opportunities, my conclusion is that Air Liquide may be superior to most broad index constituents in business quality, but at the current price it may not clearly beat the index in expected return. The S&P 500 is certainly a more diversified asset and covers about 80% of the U.S. investable market capitalization. Air Liquide offers higher business understandability and exposure to European industrial infrastructure. If you could hold only 5 assets, I would say it deserves a place on the candidate list, but whether it enters the final portfolio depends on whether you can buy it at a meaningfully lower price. At today's price, it is not enough for me to rank it as a must-buy.
Investment Checklist
| Item | Judgment | Brief comment |
|---|---|---|
| Can I understand this business? | Pass | Basic industrial gases + long-term contracts + network assets; clear economic logic |
| Does it have stable long-term demand? | Pass | Industrial, Healthcare, and Electronics all have continuing demand; Healthcare is defensive |
| Does it have a durable moat? | Pass | Scale, network, certification, contracts, and execution combine to form it |
| Does it have pricing power? | Pass | Large Industries has energy pass-through; Industrial Merchant has continuous price adjustment ability |
| Can it generate stable free cash flow? | Pass | But free cash flow is constrained by high capex; this is not an asset-light model |
| Is its return on capital excellent? | Pass | Recurring ROCE has been above 10% for many consecutive years |
| Is management trustworthy? | Pass | Strong ability to deliver targets; overall messaging is restrained |
| Is capital allocation rational? | Mostly pass | Dividends are steady and buybacks restrained, but large acquisitions still need verification |
| Is the balance sheet solid? | Pass | Low leverage, high ratings, and strong interest coverage |
| Is valuation below intrinsic value? | Fail | Current price is closer to the bull scenario |
| Is the margin of safety sufficient? | Fail | Quality is excellent, but the price is not generous |
| Would I feel comfortable holding it long term? | Pass | If bought at a reasonable price, it would be relatively comfortable to hold |
| What key facts would make me sell? | See below | ROCE decline, margin reversal, acquisition returns falling short |
| Am I only interested because the share price has risen or sentiment is strong? | Needs self-check | High-quality leaders most easily make investors ignore valuation because of quality |
Note: The judgments above synthesize company annual reports / results activity reports, the Q1 2026 report, governance and ratings disclosures, and current market valuation information. “Is valuation below intrinsic value” and “Is the margin of safety sufficient” are investment judgments based on the valuation assumptions in this report, not company-disclosed facts.
Open questions and limitations. Three points should be reserved. First, maintenance capital expenditure is not publicly disclosed, so the owner earnings estimate inevitably contains subjective judgment. Second, Reuters pages in different regions show real-time prices slightly differently. In the valuation, I mainly used its market capitalization and official share count to derive a current price anchor of about EUR 183. Third, some peer P/B, P/FCF, and ROIC data were not complete in the accessible primary sources for this report, so relative valuation is better treated as a directional reference rather than a mechanical score.
Final Investment Conclusion
【Final Rating】 Watch
【One-Sentence Investment Thesis】 Air Liquide is a high-quality industrial gas leader suitable for long-term ownership, but at the current share price of about EUR 183, investors are buying “excellent quality” rather than “clear undervaluation.”
【Core Bull Case】 The company has a compound moat built from long-term contracts, network density, certification barriers, and customer stickiness. Over the past five years, margins have continued to improve and recurring ROCE has stayed above 10%, showing that growth is not merely expansion-driven. Operating cash flow is strong, the balance sheet is robust, credit ratings are high, and net debt has declined year by year. Electronics, Healthcare, Industrial Merchant, and decarbonization projects provide higher-quality growth sources than traditional chemicals. Management's ability to deliver targets over the past few years has been stronger than that of most European industrial companies.
【Core Bear Case】 The current valuation is not low and lacks the margin of safety required by classic value investing. The company remains asset-heavy, capital expenditure is high, and the free cash flow yield is not high. New growth curves, especially hydrogen and decarbonization projects, look in the near term more like heavy investment than proven high-return businesses. Synergies and returns from large acquisitions such as DIG Airgas still need time to be tested. If margin improvement slows, the high multiple the market is willing to pay could be reduced quickly.
【Key Assumptions】 For the investment logic to hold, at least the following conditions need to be met: the company can still maintain comparable segment growth around the mid-single digits over the next ten years; recurring ROCE remains above 10%; margin improvement does not materially reverse; DIG Airgas and Electronics / decarbonization projects generate returns above the cost of capital; growth investment within capital expenditure ultimately turns into higher cash flow rather than merely a larger balance sheet.
【Fair Buy Price】 My preferred fair buy range is EUR 100-130. If you are willing to accept a lower margin of safety while placing greater weight on company quality, EUR 130-145 can also be discussed. Above that, the investment logic increasingly shifts from “value return” to “quality premium.” The basis comes from the owner earnings discount method, the base intrinsic value range, and the currently low free cash flow yield.
【Target Holding Period】 Suitable for at least 10 years. The true value of this company lies not in the next two or three quarters, but in its continuously compounding contract structure, network assets, and capital allocation discipline.
【Expected Annualized Return】 In my view, a more reasonable three-scenario expectation is: about 1%-4% per year in the conservative scenario, about 5%-7% per year in the base scenario, and about 8%-10% per year in the bull scenario. This range is derived from the current dividend yield of about 2%, medium- to long-term organic growth potential around 5%, and varying degrees of valuation compression or maintained premium. It is an estimate, not a forecast.
【Maximum Loss Risk】 If European industrial demand remains weak over the next few years, returns on hydrogen and decarbonization projects fall short, and the valuation falls from about 30x P/E to a more ordinary 18-20x range, then a medium-term share price decline to EUR 110-130 would not be exaggerated. That would imply a drawdown of about 30%-40% from the current price. In a worse scenario, if earnings are also pressured, the decline could widen to around 50%. This is not the base forecast. It is a scenario analysis of how permanent capital loss could occur.
【Tracking Indicators】 The most important indicators to track going forward are: comparable revenue growth; growth by Gas & Services segment; recurring operating margin; recurring ROCE; cash flow from operating activities and net operating cash flow; capital expenditure intensity; net debt/EBITDA; profit and cash contributions after DIG Airgas integration; Electronics and Healthcare growth; investment backlog and 12-month portfolio of investment opportunities.
【Signals That Would Trigger Reassessment】 I would reassess if the following occur: margin improvement stalls for two consecutive years; recurring ROCE falls below 10% and remains there; net debt rises materially and the rating outlook weakens; major projects are delayed, impaired, or suffer materially lower returns; growth in the two high-quality businesses, Electronics and Healthcare, loses momentum; the company starts sacrificing shareholder returns for scale.
【Final Recommendation】 Calmly stated, Air Liquide is more like a high-quality company worth tracking for the long term and worth buying at a better price, rather than one that requires immediate action today. From an owner's perspective, my answer is: the business is good, the moat is deep, management is reliable, and cash flow is real; however, at the current price, the margin of safety is insufficient for me to issue a Buy rating. For a balanced and conservative long-term investor, the best action is often to wait for a good company to meet bad sentiment before buying.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free